Held the 2026 Annual Meeting of Shareholders on June 18, 2026. Achieved a quorum with 58,010,900 shares represented, accounting for 80.04% of the total shares outstanding. Re-elected Thomas J. Cable, Peter A. Demopulos, M.D., and Diana T. Perkinson, M.D. as Class II directors with terms expiring in 2029. Approved an advisory resolution regarding the compensation of named executive officers. Approved the Amended and Restated Omeros Corporation Omnibus Incentive Compensation Plan. Ratified the appointment of Ernst & Young LLP as the independent auditor for the fiscal year ending December 31, 2026.